DiscoverThePrintThePrintPod: Antibiotic Zaynich holds promise of becoming ‘game-changer’ in fight against antimicrobial resistance
ThePrintPod: Antibiotic Zaynich holds promise of becoming ‘game-changer’ in fight against antimicrobial resistance

ThePrintPod: Antibiotic Zaynich holds promise of becoming ‘game-changer’ in fight against antimicrobial resistance

Update: 2024-12-191
Share

Description

Mumbai-based Wockhardt has completed phase 3 clinical trials in nearly 400 patients. Pharma firm looking to file for regulatory approvals in India, US and other countries in 2025.
Comments 
In Channel
ThePrintAM

ThePrintAM

2024-12-2304:28

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

ThePrintPod: Antibiotic Zaynich holds promise of becoming ‘game-changer’ in fight against antimicrobial resistance

ThePrintPod: Antibiotic Zaynich holds promise of becoming ‘game-changer’ in fight against antimicrobial resistance

ThePrint